These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 23799043)
1. Prognostic significance of HIF-1α expression in hepatocellular carcinoma: a meta-analysis. Zheng SS; Chen XH; Yin X; Zhang BH PLoS One; 2013; 8(6):e65753. PubMed ID: 23799043 [TBL] [Abstract][Full Text] [Related]
2. Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis. Ding ZN; Dong ZR; Chen ZQ; Yang YF; Yan LJ; Li HC; Liu KX; Yao CY; Yan YC; Yang CC; Li T J Gastroenterol Hepatol; 2021 Jun; 36(6):1487-1496. PubMed ID: 33393670 [TBL] [Abstract][Full Text] [Related]
3. Elevated LncRNA TRERNA1 correlated with activation of HIF-1α predicts poor prognosis in hepatocellular carcinoma. Qian Y; Li Y; Ge Y; Song W; Fan H Pathol Res Pract; 2021 Nov; 227():153612. PubMed ID: 34560417 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis. Wang D; Zhang X; Lu Y; Wang X; Zhu L Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. Dai CX; Gao Q; Qiu SJ; Ju MJ; Cai MY; Xu YF; Zhou J; Zhang BH; Fan J BMC Cancer; 2009 Dec; 9():418. PubMed ID: 19948069 [TBL] [Abstract][Full Text] [Related]
6. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related]
7. Protein expression of hypoxia-inducible factor-1 alpha and hepatocellular carcinoma: a systematic review with meta-analysis. Cao S; Yang S; Wu C; Wang Y; Jiang J; Lu Z Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):598-603. PubMed ID: 24835771 [TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis. Méndez-Blanco C; Fernández-Palanca P; Fondevila F; González-Gallego J; Mauriz JL Ther Adv Med Oncol; 2021; 13():1758835920987071. PubMed ID: 33613697 [TBL] [Abstract][Full Text] [Related]
9. The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Xiang ZL; Zeng ZC; Fan J; Tang ZY; He J; Zeng HY; Chang JY Mol Biol Rep; 2012 Feb; 39(2):2021-9. PubMed ID: 21647551 [TBL] [Abstract][Full Text] [Related]
10. Dishevelled Associated Activator Of Morphogenesis (DAAM) Facilitates Invasion of Hepatocellular Carcinoma by Upregulating Hypoxia-Inducible Factor 1α (HIF-1α) Expression. Fang X; Zhang D; Zhao W; Gao L; Wang L Med Sci Monit; 2020 Aug; 26():e924670. PubMed ID: 32772041 [TBL] [Abstract][Full Text] [Related]
11. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery. Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380 [TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis. Zhou J; Huang S; Wang L; Yuan X; Dong Q; Zhang D; Wang X World J Surg Oncol; 2017 May; 15(1):104. PubMed ID: 28521842 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in patients with bone tumor: a systematic review and meta-analysis. Luo D; Ren H; Zhang W; Xian H; Lian K; Liu H J Orthop Surg Res; 2019 Feb; 14(1):56. PubMed ID: 30782196 [TBL] [Abstract][Full Text] [Related]
14. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. Huang GW; Yang LY; Lu WQ World J Gastroenterol; 2005 Mar; 11(11):1705-8. PubMed ID: 15786555 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma. Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma. Hu F; Deng X; Yang X; Jin H; Gu D; Lv X; Wang C; Zhang Y; Huo X; Shen Q; Luo Q; Zhao F; Ge T; Zhao F; Chu W; Shu H; Yao M; Fan J; Qin W Oncogene; 2015 Dec; 34(49):6007-17. PubMed ID: 25745995 [TBL] [Abstract][Full Text] [Related]
17. Association of hypoxia-inducible factor 1α expression with susceptibility to hepatitis B virus-related hepatocellular carcinoma: A meta-analysis. Wang L; Peng JL Int J Biol Markers; 2023 Dec; 38(3-4):149-158. PubMed ID: 37787154 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis. Huang M; Chen Q; Xiao J; Yao T; Bian L; Liu C; Lin Z Int J Gynecol Cancer; 2014 Jul; 24(6):1054-64. PubMed ID: 24978711 [TBL] [Abstract][Full Text] [Related]
19. Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma. Li XP; Yang XY; Biskup E; Zhou J; Li HL; Wu YF; Chen ML; Xu F Oncotarget; 2015 Sep; 6(26):22880-9. PubMed ID: 26078356 [TBL] [Abstract][Full Text] [Related]
20. 14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α. Tang Y; Liu S; Li N; Guo W; Shi J; Yu H; Zhang L; Wang K; Liu S; Cheng S Oncotarget; 2016 Mar; 7(13):15854-67. PubMed ID: 26910835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]